3 Charts Showing How Moderna Performed After Its Latest Earnings Reports
In recent times, Moderna (NASDAQ: MRNA) shares haven't exactly been stock market superstars. The stock that climbed 1,200% over the past two years has lost a good deal of momentum. It's dropped 39% year to date. So, investors may be wondering what could offer shares of this coronavirus vaccine giant a boost.
The company reports earnings on May 4. Considering Moderna's $21 billion in advance purchase agreements for this year, we may expect another billion-dollar quarter. Could that sort of news boost the shares? For some clues, let's check out what Moderna shares did in the months following the past three earnings reports.
Image source: Getty Images.
Source Fool.com
